The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
A tale of two proteins: Differential roles and regulation of Smad2 and Smad3 in TGF‐β signaling
Abstract
Transforming growth factor‐beta (TGF‐β) is an important growth inhibitor of epithelial cells, and insensitivity to this cytokine results in uncontrolled cell proliferation and can contribute to tumorigenesis. Smad2 and Smad3 are direct mediators of TGF‐β signaling, however little is known about the selective activation of Smad2 versus Smad3. The Smad2 and Smad3 knockout mouse phenotypes and studies comparing Smad2 and Smad3 activation of TGF‐β target genes, suggest that Smad2 and Smad3 have distinct roles in TGF‐β signaling. The observation that TGF‐β inhibits proliferation of Smad3‐null mammary gland epithelial cells, whereas Smad3 deficient fibroblasts are only partially growth inhibited, suggests that Smad3 has a different role in epithelial cells and fibroblasts. Herein, the current understanding of Smad2 and Smad3‐mediated TGF‐β signaling and their relative roles are discussed, in addition to potential mechanisms for the selective activation of Smad2 versus Smad3. Since alterations in the TGF‐β signaling pathway play an important role in promoting tumorigenesis and cancer progression, methods for therapeutic targeting of the TGF‐β signaling pathway are being pursued. Determining how Smad2 or Smad3 differentially regulate the TGF‐β response may translate into developing more effective strategies for cancer therapy. J. Cell. Biochem. 101: 9–33, 2007. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–209 of 209
BRCA2 and Smad3 synergize in regulation of gene transcription
Preobrazhenska, O., Yakymovych, M., Kanamoto, T., Yakymovych, I., Stoika, R. S., Heldin, C., & Souchelnytskyi, S. (2002) · Oncogene · doi:10.1038/sj.onc.1205732 · Cited by 33
SRF is a nuclear repressor of Smad3-mediated TGF-β signaling
Lee, H.-J., Yun, C.-H., Lim, S., Kim, B.-C., Baik, K. G., Kim, J.-M., Kim, W. H., & Kim, S. J. (2006) · Oncogene · doi:10.1038/sj.onc.1209774 · Cited by 33
Prokova, V. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki679 · Cited by 32
Identification of novel Smad binding proteins
Warner, D. R., Roberts, E. A., Greene, R. M., & Pisano, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.049 · Cited by 30
The role of PRAJA and ELF in TGF-β signaling and gastric cancer
Mishra, L., Katuri, V., & Evans, S. R. T. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.7.2015 · Cited by 28
Piek, E., van Dinther, M., Parks, W. T., SALLEE, J. M., Böttinger, E. P., Roberts, A. B., & ten Dijke, P. (2004) · Biochemical Journal · doi:10.1042/bj20040774 · Cited by 18
Lacorte, J., Beigneux, A. P., Parant, M., & Chambaz, J. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01127-7 · Cited by 18
Feifei, C. H. E. N., Ogawa, K., Xubao, L. I. U., Stringfield, T. M., & Chen, Y. (2002) · Biochemical Journal · doi:10.1042/bj20011703 · Cited by 17
Tada, K., Inoue, H., Ebisawa, T., Makuuchi, M., Kawabata, M., Imamura, T., & Miyazono, K. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00293.x · Cited by 14
Cited by
Regulation of TGF-β signaling by Smad7
Yan, X., Liu, Z., & Chen, Y. (2009) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmp018 · Cited by 436
Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review
Cao, H., Xu, E., Liu, H., Wan, L., & Lai, M. (2015) · Pathology - Research and Practice · doi:10.1016/j.prp.2015.05.010 · Cited by 356
Transforming growth factor-β in myocardial disease
Frangogiannis, N. G. (2022) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00646-w · Cited by 344
SMAD2,SMAD3 and SMAD4 Mutations in Colorectal Cancer
Fleming, N. I., Jorissen, R. N., Mouradov, D., Christie, M., Sakthianandeswaren, A., Palmieri, M., Day, F., Li, S., Tsui, C., Lipton, L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2706 · Cited by 324
Pretzsch, E., Bösch, F., Neumann, J., Ganschow, P., Bazhin, A., Guba, M., Werner, J., & Angele, M. (2019) · Journal of Oncology · doi:10.1155/2019/7407190 · Cited by 298
Metadata
- Authors
- Brown, K. A., Pietenpol, J. A., & Moses, H. L.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2007-03-05
- Volume
- 101
- Issue
- 1
- Pages
- 9-33
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2129063289
- Cited by
- 358
- References
- 209
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.